Can Kailera become the next major GLP-1 challenger after pricing one of biotech’s biggest IPOs in years?
UCB SA (EBR: UCB) bets $1.15 bn on Neurona Therapeutics to push epilepsy treatment beyond symptom control
Read More Technology Industry News Sally Beauty taps Infosys to modernize IT with AI and hyper-automation Infosys, a global leader in next-generation digital services and consulting, has announced a strategic collaboration with Sally Beauty… byPallavi MadhirajuOctober 5, 2024